Page 29
Payne whistled softly. “I stand corrected.”
“Second, as to motive, I suppose it depends on how much one loses relative to how much one can afford to lose. And the Mob used to whack people in broad daylight all the time.”
“Damn it. You’re right again, of course. Jason’s voice just popped in my head. It is a stone to turn over. And likely a big one. What happened with the company?”
“According to the discussion boards, investors lost confidence.” He pointed to the chart. “Here, some people bailed at or near the top at a dime a share. Others lost money as shares collapsed back to around a penny. Many wrote online that they had given up on a return on investment. At this point, they would have been satisfied with just a return of investment.”
“So, what caused the stock to nose-dive?”
“Apparently the company could not provide proof that they (a) actually had a physical product that did what they claimed and (b) one that would be approved by the FDA. Medical device approval by the feds, from what I’ve picked up, is tough as hell. And without that, they had no marketable product. Remember the phrase patent pending? Well, that’s about what they have. Lots of paperwork filed with the U.S. Patent Office. And when certain shareholders asked for independent scientific proof the device worked, Benson said that the company would not show a product until their intellectual property was safely under their patent, then berated them as short sellers bad-mouthing the company in order to profit on the share price drop.”
“Sounds like The Wizard of Oz: ‘Pay no attention to that man behind the curtain.’”
“Exactly. And when you get an idea of what the device is supposed to do, you really wonder . . . It’s futuristic . . .”
Payne gestured for him to go on.
“Remember those eyeglasses they came out with that let you surf the Internet? You essentially are wearing a computer and no one knows what you’re viewing.”
“Yeah. That was futuristic by itself.”
“This goes another step further. Instead of glasses, they’re like contact lenses. The surface of an eyeball is a sort of one-stop shop. It can give these special lenses your body’s vital information—temperature, pulse, et cetera. They claim the lenses can also monitor a person’s level of medication. It works with a mobile phone—specifically, a smartphone—”
“Which is actually just a small, powerful computer that happens to also work as a telephone,” Payne put in, tapping his on the bar.
“Right. And because it’s also a phone, it can send a report to your doctor. Let’s say you’re diabetic. The user puts an app on the smartphone that checks blood sugar levels and warns you before it’s too low or high. Or if you’re, say, schizophrenic, the app can tell if you’re on your meds—and, if not, then send a report to your doctor. They claim—again, key word claim—eventually the next level will be maintaining medication, so the doctor can send a command that administers your meds through another device.”
“Jesus. Amazing. No more crazies? Or, at least, fewer? That’s huge. So is reducing diabetic comas.”
Harris said, “And that, supposedly, is the tip of the iceberg.”
“What powers the lenses, and how do they communicate to the phone? I mean, you can’t really have wires hanging from your eyeballs.”
“Exactly. Good questions. And that seems to be exactly what the investors also want to know.”
“So it’s futuristic. And it’s incredible. But, then, so was the smartphone not too many years ago. Still, if there’s no patent and no FDA-approved device, it’s all speculation. Investors are gambling—arguably, more than usual.” He looked back at the chart. “What am I missing? What caused this spike in price at a dime?”
“News that there’s been some interest by much larger companies, which suddenly gave the device and company some credibility. The suggestion was made—Benson was accused of using a shill to feed it on the discussion boards—that NextGen was the target of a takeover, and, if that failed to go through, then that the bigger companies would license use of the technology. Sound like another penny stock tale, one that has a happy ending?”
“And it went down again today,” Payne said, pointing at the sheet. And then his eyebrows rose. “Maybe we should look into getting some shares. Damn, sure looks cheap now.”
“Might want to wait and see what happens when news of Benson’s death goes public,” Harris said, then grunted. “But, then, I’ve already warned you about taking investment advice from me.”
He took a long drink of his club soda.
“Right now,” Harris then said, “until we talk with Austin, it’s the best we have to go on. I also left a message for McGuire asking for a list, if there is one, of anyone requesting protection for the Camilla’s Kids event.”
Lieutenant Gerry McGuire, a somewhat plump, pleasant-looking forty-five-year-old, was the commanding officer of Dignitary Protection.
Payne nodded, and he said, “Let’s plan on being at Hahnemann when Austin wakes up tomorrow morning. See what we can get out of him. Then, if I don’t hear back from Mason Morgan—I’ve left voice mail messages on three different numbers—we’ll make a surprise courtesy call at his office . . . Anything new on the shooter’s van?”
“Well, the doers are still in the wind. Not a trace of the bastards. And not much in the van. There was a little blood in back—like, maybe, from a bloody nose. And the spent shotgun shells. And a burner phone, which Krow’s techs are going through.
“The security video files that McCrory got from the steak house cameras show the van turning off Walnut and parking at the driveway entrance about an hour before the shooting. The driver—a short, skinny white male—got out to put the orange cones at the front and back bumpers but was very careful to keep his back to the curb and keep his head down to conceal his face. All that can be seen of him is his clothing, including a black cap and gloves.”
“And the gloves suggest the crime scene guys will be shit outta luck on getting fingerprints off anything—the phone, the shells, the vehicle.”
“The plates that were on the vehicle came off another white Chevy van, ident
Table of Contents
- Page 1
- Page 2
- Page 3
- Page 4
- Page 5
- Page 6
- Page 7
- Page 8
- Page 9
- Page 10
- Page 11
- Page 12
- Page 13
- Page 14
- Page 15
- Page 16
- Page 17
- Page 18
- Page 19
- Page 20
- Page 21
- Page 22
- Page 23
- Page 24
- Page 25
- Page 26
- Page 27
- Page 28
- Page 29 (Reading here)
- Page 30
- Page 31
- Page 32
- Page 33
- Page 34
- Page 35
- Page 36
- Page 37
- Page 38
- Page 39
- Page 40
- Page 41
- Page 42
- Page 43
- Page 44
- Page 45
- Page 46
- Page 47
- Page 48
- Page 49
- Page 50
- Page 51
- Page 52
- Page 53
- Page 54
- Page 55
- Page 56
- Page 57
- Page 58
- Page 59
- Page 60
- Page 61
- Page 62
- Page 63
- Page 64
- Page 65
- Page 66
- Page 67
- Page 68
- Page 69
- Page 70
- Page 71
- Page 72
- Page 73
- Page 74
- Page 75
- Page 76
- Page 77
- Page 78
- Page 79
- Page 80
- Page 81
- Page 82
- Page 83
- Page 84
- Page 85
- Page 86
- Page 87
- Page 88
- Page 89
- Page 90
- Page 91
- Page 92
- Page 93
- Page 94
- Page 95
- Page 96
- Page 97
- Page 98
- Page 99
- Page 100
- Page 101
- Page 102
- Page 103
- Page 104
- Page 105
- Page 106
- Page 107
- Page 108
- Page 109
- Page 110
- Page 111
- Page 112
- Page 113
- Page 114
- Page 115
- Page 116
- Page 117
- Page 118
- Page 119
- Page 120
- Page 121
- Page 122
- Page 123
- Page 124
- Page 125
- Page 126
- Page 127
- Page 128
- Page 129
- Page 130
- Page 131
- Page 132
- Page 133
- Page 134
- Page 135